Vertex Pharma Stock Price (NASDAQ:VRTX)

Add to My Stocks
$86.07 $0.34 (0.4%) VRTX stock closing price Feb 24, 2017 (Closing)
Vertex Pharma
24 FEB 2017
amigobulls logo
VRTX hand_up
VRTX vs S&P 500
Closing Price: Feb 24, 2017
$86.07 ( 0.4%)
S&P 500
2367.3 ( 0.15%)
52 Week Price Range
1 Year Return: 0.23%
Q4 Growth*
On Par
Profitable ?
net image
2016 Q4 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Vertex Pharma Snapshot Video

12 5 2

VRTX Stock Details

Prev Close* : $85.73
Market Cap:
Day Low: $84.62
52 Week Low: $71.46
Open: $85.73
Volume: 1406789
Day High: $86.11
52 Week High: $103.73

Latest Stock Market News

Latest Articles

Vertex Pharma News - From Partners

VRTX Stockcharts

View VRTX PE ratio, PS ratio stocks charts and compare with peers.
VRTX Chart
Note: Compare Vertex Pharma stock price history with the index and industry peers.

Vertex Pharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

VRTX Industry Peers

Company Price Change (%)
Illumina (ILMN)1601.01 (0.63%)
Incyte (INCY)131.219.26 (7.59%)
Johnson & Johnson (JNJ)122.731.03 (0.85%)
Nivalis Therapeutics (NVLS)2.590.1 (4.02%)
Proqr Therapeutics (PRQR)4.050 (0%)
Galapagos (GLPG)69.360.6 (0.86%)
Ptc Therapeutics (PTCT)13.160.09 (0.69%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Incyte (INCY)131.219.26 (7.59%)
Sarepta Therapeutics (SRPT)32.021.87 (6.2%)
Stemline Therapeutics (STML)6.850.4 (6.2%)
Bluebird Bio (BLUE)823.7 (4.73%)
Puma Biotech (PBYI)36.21.5 (4.32%)
Sangamo BioSciences (SGMO)40.15 (3.9%)
Epizyme (EPZM)12.150.45 (3.85%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 25, 2017
CompanyPriceChange (%)
Achillion Pharma (ACHN)3.860.38 (8.96%)
Chromadex (CDXC)2.740.13 (4.53%)
Idera Pharma (IDRA)1.670.06 (3.47%)
Inovio Pharma (INO)6.680.22 (3.19%)
VIVUS (VVUS)1.140.03 (2.56%)
Ligand Pharma (LGND)100.382.46 (2.39%)
Compugen (CGEN)4.30.1 (2.27%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 25, 2017

Vertex Pharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues1.7B1.03B580.41M1.21B1.53B
Net Income-112.05M-556.33M-738.55M-445.02M-107.03M
Total Operating Expense-1.37B1.21B1.99B1.24B
view Vertex Pharmaceuticals Incorporated income statement
balance sheet20152014201320122011
Total Assets2.5B2.33B2.32B2.76B2.2B
Total Liabilities1.41B1.24B962.63M1.56B1.28B
Shareholders Equity1.09B1.1B1.36B1.2B928.47M
view Vertex Pharmaceuticals Incorporated balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-85.94M-11.06M-5.05M-13.78M-193.06M
Net Cash From (Used By) Operating Activities-365.43M-513.19M-51.57M267.84M143.73M
Increase (Decrease) In Prop Plant And Equipment-45.3M-51.2M-51.39M-71.14M-34.59M
view Vertex Pharmaceuticals Incorporated cashflow statement

Vertex Pharmaceuticals Incorporated Stock News - Partner Headlines

Vertex Pharma Stock Message Board

As of last trading day, Vertex Pharma stock price was 86.07. Vertex Pharma market capitalization is 21.29B and it represents the total market value of VRTX stock. A value investor must look at the fundamentals of a stock, and perform Vertex Pharma valuation, even though in the short-term sentiment and current breaking news might affect Vertex Pharma stock price.

The terms stocks and shares mean the same thing. For Ex: Vertex Pharma stock price and Vertex Pharma share price mean the same thing. The volume of shares traded stood at 1406789 on the last trading day, as is evident from Vertex Pharma stock chart, and VRTX stock quote data. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Vertex Pharma does not pay dividends. One can observe stock price trends and check for volatility by checking Vertex Pharma stock price history.